Search results for "biopsy"

showing 10 items of 1352 documents

Estimating the Patient-Specific Relative Stiffness Between a Hepatic Lesion and the Liver Parenchyma

2017

This paper presents a novel non-invasive methodology to obtain the patient-specific relative stiffness between a hepatic lesion and the liver parenchyma in vivo. This relative stiffness can be used as a biomarker about the type of lesion. This biomarker together with the rest of pathological information can be used to plan a biopsy, an image-guide intervention or a radiation therapy. This relative stiffness is estimated by means of the finite element simulation of the breathing process, which is embedded in an optimization routine based on genetic algorithms. This routine was aimed at finding the patient-specific relative stiffness between a hepatic lesion and the liver parenchyma for the p…

0301 basic medicinemedicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentPatient specificHepatic malignancy030218 nuclear medicine & medical imagingRadiation therapyLesion03 medical and health sciences030104 developmental biology0302 clinical medicineBiopsymedicineBiomarker (medicine)Radiologymedicine.symptombusinessLiver parenchymaRelative stiffness
researchProduct

PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients

2019

Dyslipidemia and altered iron metabolism are typical features of nonalcoholic fatty liver disease (NAFLD). Proprotein convertase subtilisin/kexin type 7 (PCSK7) gene variation has been associated with circulating lipids and liver damage during iron overload. The aim of this study was to examine the impact of the PCSK7 rs236918 variant on NAFLDrelated traits in 1,801 individuals from the Liver Biopsy Cohort (LBC), 500,000 from the UK Biobank Cohort (UKBBC), and 4,580 from the Dallas Heart Study (DHS). The minor PCSK7 rs236918 C allele was associated with higher triglycerides, aminotransferases, and hepatic inflammation in the LBC (P < 0.05) and with hypercholesterolemia and liver disease …

0301 basic medicinenonalcoholic fatty liver diseasemedicine.medical_specialtyDyslipidemias; Genetics; Inflammation; Liver; Triglycerides; genes in lipid dysfunction; metabolic disease; non-alcoholic fatty liver diseaseHyperlipidemiasInflammationQD415-436030204 cardiovascular system & hematologyBiochemistryproprotein convertase subtilisin/kexin type 703 medical and health sciencesLiver disease0302 clinical medicineEndocrinologyGeneticInternal medicineNonalcoholic fatty liver diseasemedicineGeneticsHumansSubtilisinsAlleleTriglyceridesDyslipidemiasHypertriglyceridemiaInflammationgenes in lipid dysfunctionmedicine.diagnostic_testbusiness.industrynon-alcoholic fatty liver diseaseCell Biologymedicine.diseasemetabolic disease030104 developmental biologyEndocrinologyLiverLiver biopsyLipogenesisKexinmedicine.symptomPatient-Oriented and Epidemiological ResearchbusinessDyslipidemia
researchProduct

Exosomal HSP60: a potentially useful biomarker for diagnosis, assessing prognosis, and monitoring response to treatment.

2017

Introduction: Cell-to-cell communication is imperative for life and it is mediated by sending and receiving information via the secretion and subsequent receptor-mediated detection of biological molecules. Exosomes (EXs) secreted from cells to the extracellular environment play an important role in intercellular communication in normal and pathological conditions. Areas covered: New evidence indicates that tumor cells-derived EXs contribute to cancer progression through the modulation of tumor microenvironment. The exosomal heat shock protein 60 (HSP60) is very likely a key player in intercellular cross-talk, particularly during the progress of diseases, such as cancer. Many studies have fo…

0301 basic medicinetheranostic2734BiologyExosomesPathology and Forensic Medicine03 medical and health sciencesExtracellular VesiclesImmune systemHeat shock proteinNeoplasmsGeneticsmedicineBiomarkers TumorAnimalsHumansMolecular Targeted TherapyLiquid biopsyExtracellular Vesicles (EVs)Molecular BiologyCancerTumor microenvironmentLiquid BiopsyExosomes (EXs)CancerChaperonin 60medicine.diseasePrognosisHeat Shock Protein 60 (HSP60)MicrovesiclesBiomarker030104 developmental biologyTreatment OutcomeImmunologyCancer researchMolecular MedicineHSP60BiomarkersExpert review of molecular diagnostics
researchProduct

Giant cell arteritis (Horton's disease) in very elderly patients aged 80 years and older: A study of 25 cases

2015

Aim Analysis of the characteristics of very elderly patients with giant cell arteritis (GCA). Methods Patients aged 80 years and older diagnosed with GCA in our department between 1 January 2002 and 31 July 2008 were retrospectively included. For each patient, we recorded general characteristics, reason(s) for hospitalization, specialty of the physician or department that referred the patient to us, medical history, treatment at admission, GCA clinical features, time to diagnosis of GCA, biological screening and GCA treatment. Results We analyzed 25 clinical records, 18 women and seven men with a mean age of 83.9 years. General weakness, visual loss and inflammatory syndrome were the princi…

030203 arthritis & rheumatologyWeaknessPediatricsmedicine.medical_specialtyeducation.field_of_studymedicine.diagnostic_testbusiness.industryPopulationSpecialtyDiseasemedicine.diseaseSurgeryVery frequent030207 dermatology & venereal diseases03 medical and health sciencesGiant cell arteritis0302 clinical medicineBiopsymedicineMedical historymedicine.symptombusinesseducationGeriatrics & Gerontology International
researchProduct

Local complications associated with labial salivary gland biopsy for diagnosis of Sjögren?s Syndrome : a retrospective cohort study

2019

Background To describe local or systemic complications related to the labial salivary glands biopsy (LSGB) used as diagnostic tool for the diagnosis of Sjogren's Syndrome (SS). Material and methods Clinical databases from a cohort of patients, who underwent LSGB with provisional clinical diagnosis of Sjogren's Syndrome, were retrospectively reviewed. Pain, assessed by registering the intake of analgesic drugs in the first week following the biopsy, and any further relevant clinical information regarding complications after biopsy were recorded. Results 50 patients received LSGB. 10 of them (9 women and 1 man) showed histopathological findings compatible with SS. Ten patient (20%) receiving …

030203 arthritis & rheumatologymedicine.medical_specialtyOral Medicine and Pathologymedicine.diagnostic_testbusiness.industryResearchAnalgesicRetrospective cohort study030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Surgery03 medical and health sciencesLabial salivary gland0302 clinical medicineBiopsy SiteUNESCO::CIENCIAS MÉDICASBiopsyCohortmedicineSjogren sAdverse effectbusinessGeneral Dentistry
researchProduct

Liquid biomarkers for fibrotic NASH – progress in a complex field

2022

0303 health sciencesComplex fieldPathologymedicine.medical_specialtyHepatologymedicine.diagnostic_testbusiness.industryLiver fibrosis03 medical and health sciences0302 clinical medicineLiver biopsyMedicine030211 gastroenterology & hepatologybusiness030304 developmental biologySerum markersJournal of Hepatology
researchProduct

Sural nerve biopsy studies in leigh's subacute necrotizing encephalomyelopathy

1986

Peripheral neuropathy marked by reduced nerve conduction velocities was found in four unrelated children, between the ages of 15 months and 9 years, whose autopsies revealed Leigh's subacute necrotizing encephalomyelopathy. Sural nerve biopsies disclosed primary demyelination and remyelination, as well as loss of myelinated and unmyelinated axons. The use of morphometric and electron microscopic studies shows that these techniques may reveal peripheral neuropathy in Leigh's disease more often than light microscopic methods alone.

0303 health sciencesPathologymedicine.medical_specialtymedicine.diagnostic_testPhysiologyPrimary demyelinationbusiness.industrySural nerveSural nerve biopsymedicine.disease03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicinemedicine.anatomical_structurePeripheral neuropathyPhysiology (medical)BiopsymedicineNeurology (clinical)RemyelinationLeigh diseasebusinessElectron microscopic030217 neurology & neurosurgery030304 developmental biologyMuscle & Nerve
researchProduct

2020

In midlife, women experience hormonal changes due to menopausal transition. A decrease especially in estradiol has been hypothesized to cause loss of muscle mass. This study investigated the effect of menopausal transition on changes in lean and muscle mass, from the total body to the muscle fiber level, among 47–55-year-old women. Data were used from the Estrogenic Regulation of Muscle Apoptosis (ERMA) study, where 234 women were followed from perimenopause to early postmenopause. Hormone levels (estradiol and follicle stimulating hormone), total and regional body composition (dual-energy X-ray absorptiometry (DXA) and computed tomography (CT) scans), physical activity level (self-reported…

0303 health sciencesmedicine.medical_specialtyMuscle biopsymedicine.diagnostic_testbusiness.industrySkeletal muscle030209 endocrinology & metabolismGeneral Medicinemedicine.diseasePhysical activity levelMenopause03 medical and health sciencesFollicle-stimulating hormone0302 clinical medicineEndocrinologymedicine.anatomical_structureSarcopeniaInternal medicinemedicineLean body massbusiness030304 developmental biologyHormoneJournal of Clinical Medicine
researchProduct

Undetectable viral RNA from SARS-CoV-2 in endometrial biopsies from women with COVID-19: a preliminary study.

2022

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiopsyObstetrics and GynecologyCOVID-19ACE2VirologyEndometriumResearch LetterMedicineHumansRNA ViralViral rnaFemalebusinessAmerican journal of obstetrics and gynecology
researchProduct

205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part II 28-30 March 2014, Naarden, The Netherlands.

2015

The idiopathic inflammatory myopathies (IM) are a heterogeneous group of diseases and diagnosis often necessitates a muscle biopsy. Five main entities are recognized: (1) dermatomyositis (DM); (2) polymyositis (PM); (3) necrotizing autoimmune myopathy (NAM); (4) sporadic inclusion body myositis (IBM); and (5) non-specific myositis. Other entities include granulomatous myopathy, macrophagic myofasciitis, and eosinophilic fasciitis (Shulman's syndrome). The pathological classification and subsequent identification of disease subgroups are extremely important for assessing treatment options and prognosis in the individual patient, yet classification criteria have not been standardized and vali…

2716 Genetics (clinical)medicine.medical_specialtyConsensusBiopsy10208 Institute of Neuropathology610 Medicine & healthPolymyositismedicineHumans2735 Pediatrics Perinatology and Child HealthColoring AgentsMyopathyGenetics (clinical)MyositisNetherlandsMuscle biopsyMyositismedicine.diagnostic_testbusiness.industryMusclesMacrophagic myofasciitisDermatomyositismedicine.diseaseDermatologyEosinophilic fasciitis2728 Neurology (clinical)Neurology2808 NeurologyPediatrics Perinatology and Child HealthPhysical therapy570 Life sciences; biologyNeurology (clinical)medicine.symptomInclusion body myositisbusinessNeuromuscular Disorders
researchProduct